압타바이오 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 이수진, was filed 08 May 2023.
압타바이오: what insiders have been doing
This page follows insider dealings at 압타바이오 as filed with DART (FSS), a company from the Health Care sector. 압타바이오 has had no insider filing for more than a year; the last one goes back to 28 May 2025.
Our records for 압타바이오 go back to 2021, with 13 purchases and 3 sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 204,897 sharesKRXDART:20250528000329
- 127,874 sharesKRXDART:20241029000393
- 95,905 sharesKRXDART:20241028000173
- 7,600 sharesShareKRXDART:20230508000015Canonical exit: 27 Jul 2023 (T+90)
- 14,208 sharesShareKRXDART:20230508000013Canonical exit: 27 Jul 2023 (T+90)
- 8,000 sharesShareKRXDART:20230424000218Canonical exit: 23 Jul 2023 (T+90)
- 9,000 sharesShareKRXDART:20230424000212Canonical exit: 23 Jul 2023 (T+90)
- 16,000 sharesShareKRXDART:20230403000581Canonical exit: 29 Jun 2023 (T+90)
- 12,000 sharesShareKRXDART:20230403001124Canonical exit: 29 Jun 2023 (T+90)
- 18,000 sharesShareKRXDART:20230327000189Canonical exit: 22 Jun 2023 (T+90)
- 15,000 sharesShareKRXDART:20230327000139Canonical exit: 22 Jun 2023 (T+90)
- 49,000 sharesShareKRXDART:20230320000452Canonical exit: 13 Jun 2023 (T+90)
- 40,000 sharesShareKRXDART:20230320000506Canonical exit: 13 Jun 2023 (T+90)
- 49,000 sharesShareKRXDART:20230320000563Canonical exit: 13 Jun 2023 (T+90)
- 10,000 sharesShareKRXDART:20220328000218Canonical exit: 23 Nov 2021 (T+90)
- 10,000 sharesShareKRXDART:20220328000189Canonical exit: 9 Nov 2020 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
19 of 19 declarations
About 압타바이오
Aptabio is a biotechnology company focused on developing therapies based on aptamers. It is listed on the XKRX market.
